Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting

PURPOSE: We report the efficacy and safety of venetoclax plus decitabine-based treatment in heavily pre-treated relapsed or refractory acute myeloid leukaemia (RR-AML) in a real-world setting. PATIENTS AND METHODS: There were 22 patients in this study and the median age was 47.5 (12–84) years old, i...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Juan, Zhao, Na, Hu, Xing, Yao, Wen, Cheng, Yaxin, Zhou, Li, Liu, Huilan, Geng, Liangquan, Sun, Zimin, Zheng, Changcheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285225/
https://www.ncbi.nlm.nih.gov/pubmed/34285581
http://dx.doi.org/10.2147/CMAR.S316561

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285225/
https://www.ncbi.nlm.nih.gov/pubmed/34285581
http://dx.doi.org/10.2147/CMAR.S316561

Ejemplares similares